Thx. I never said that, they did… they have been saying couple of molecules are near commercialisation…just trying to understand if KarXT is treated as already commercialised or not… may be that’s the question for concall now
Posts tagged Value Pickr
Kilpest India Ltd (09-02-2024)
Growth rate Should be speed up from here in diagnostics division due to lower base as whole industry is growing at fater rate…
Good Part is management commentary is also positive in agrochem division which may provide double engine growth going fwd…
Disc: Invested
Can Jain Irrigation System become part of Indian Agri Growth? (09-02-2024)
da5704ec-7c43-4f2b-b160-fd1223de0f8e.cleaned.pdf (7.0 MB)
Q3FY24 results
Kilpest India Ltd (09-02-2024)
https://www.bseindia.com/xml-data/corpfiling/AttachLive/057c94d7-5e91-462f-9103-22c2257cb67e.pdf
A good Q3 result in my view – growth continues. I had expected a bit more from the Manchester facility.
Disc.: invested
DCX Systems Ltd (09-02-2024)
It was a good con-call. Except the intermittent loss of sound.
Management is clear
- Do not judge DCX on quarterly results.
- 500cr raised, of which, 209cr goes to the JV against 60.1% ownership
- ELTA fund infusion into the JV is nil as they have spent millions in the tech and are bringing that to the table
- The product is unique and the only tech available that can detect 1km+ range to see what is on the track (obstacle, animals)
- India is a big market for this tech, considering railway tech budgets / expansions, but the product is valid globally and DCX will manufacture all the orders for the product
- The product is not a sub-system. It is fully ready to use. Comes with under railway safety as well.
- Revenue will come in end FY24 starting FY25
- The tech is different to Kavaach
- This is a standalone system with complete visibility to the driver
- Present order book Rs 1569 CR
- Of which major is exports.
- Subsidiary – invested 25-30cr in state of the art machinery. Have global approval. Also have internal consumption for the same.
- High end engineering & aerospace focus only.
- Lockheed is a major player and this is our first order. We are now in their system and will pop up as a vendor for all branches.
*could not catch parts of the call due to poor connectivity and unclear voice from the speakers.
Management is bullish. Refuse to give any number guidance. Plead to shareholders to remain patient and look at the history, we will not disappoint you, we want to grow and are very clear on the approach.
Feel like price may have seen a near-term bottom. I have added more quantity today during the call.
Let’s wait for more order updates & execution flow.
Dream on
Globus Spirits (09-02-2024)
check tax reversal. margins are down to 6%.
DHP India Ltd – Regulators and Fittings (09-02-2024)
Another quarter of terrible results. Net loss. The silver lining is that the management didn’t try to pad up the results by selling Mutual Funds.
I’m disappointed once again with the total lack of communication around why the business is facing this difficulty and what steps are being taken to overcome it.
Caplin Point Laboratories (09-02-2024)
Good Numbers
Gross Margin for Q3 FY24 is 56.3% vs 55.9% in Q3 FY23 and 9M FY24 is 57.1% vs 54.8% in 9MFY23
EBITDA Margin for Q3 FY 24 is 35.2% vs 32.0% in Q3 FY23 and 9M FY24 is 35.3 % vs 32.2% in 9MFY23, aided by new product launches across existing and new markets
Basic EPS increased by 22.2% to Rs.44.19 in 9M FY24 compared to Rs.36.17 in 9M FY23
Cash Flow from Operations in 9MFY24 is ₹189 Crores
Free Cash Flow is ₹72 Crores after Capex investment of ₹117 Crores
Geographical revenues: Latin America and the Rest of the World 83%, US 17%
Caplin Steriles Ltd (“CSL”) 9M FY24 Operating Revenue of ₹210 Crores, a 40.3% Y-o-Y growth
CSL’s revenue composition demonstrates a balanced mix of Product Supply and Milestone + Profit
Share, with the split for 9M FY24 is in the range of 75% and 25% respectivelyReceivable days are at 107 days
As of 31st Dec 2023, Inventories (including in-transit inventory) are at ₹374 Crores and Cash and
Cash equivalents are at ₹832 Crores